| 000 | 01699 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515020644.0 | ||
| 264 | 0 | _c20060727 | |
| 008 | 200607s 0 0 eng d | ||
| 022 | _a1744-6872 | ||
| 024 | 7 |
_a10.1097/01.fpc.0000197466.14340.0f _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiang, Xiao Hui | |
| 245 | 0 | 0 |
_aCD14 promoter polymorphisms have no functional significance and are not associated with atopic phenotypes. _h[electronic resource] |
| 260 |
_bPharmacogenetics and genomics _cApr 2006 |
||
| 300 |
_a229-36 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aChina _xethnology |
| 650 | 0 | 4 |
_aDermatitis, Atopic _xblood |
| 650 | 0 | 4 | _aGene Frequency |
| 650 | 0 | 4 | _aGenes, Reporter |
| 650 | 0 | 4 | _aHaplotypes |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin E _xblood |
| 650 | 0 | 4 | _aLinkage Disequilibrium |
| 650 | 0 | 4 |
_aLipopolysaccharide Receptors _xblood |
| 650 | 0 | 4 |
_aLuciferases _xmetabolism |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 |
_aSingapore _xepidemiology |
| 650 | 0 | 4 | _aSolubility |
| 700 | 1 | _aCheung, Wai | |
| 700 | 1 | _aHeng, Chew Kiat | |
| 700 | 1 | _aLiu, Jian Jun | |
| 700 | 1 | _aLi, Chun Wei | |
| 700 | 1 | _aLim, Bing | |
| 700 | 1 | _aWang, De Yun | |
| 773 | 0 |
_tPharmacogenetics and genomics _gvol. 16 _gno. 4 _gp. 229-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.fpc.0000197466.14340.0f _zAvailable from publisher's website |
| 999 |
_c16146976 _d16146976 |
||